23 Mar 2017 --- Lesaffre Human Care has announced that findings of a recent meta-analysis support claims that ibSium benefits gastrointestinal disorders. The research reveals that subjects who consumed ibSium felt 12.3% less pain/gastrointestinal discomfort than when consuming a placebo.
